Cargando…

RNAi-Based Approaches for Pancreatic Cancer Therapy

Pancreatic cancer is one of the most lethal forms of cancer, predicted to be the second leading cause of cancer-associated death by 2025. Despite intensive research for effective treatment strategies and novel anticancer drugs over the past decade, the overall patient survival rate remains low. RNA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Min Ju, Chang, Hyeyoun, Nam, Gihoon, Ko, Youngji, Kim, Sun Hwa, Roberts, Thomas M., Ryu, Ju Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541396/ https://www.ncbi.nlm.nih.gov/pubmed/34683931 http://dx.doi.org/10.3390/pharmaceutics13101638

Ejemplares similares

Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor Microenvironment
por: Park, Jooho, et al.
Publicado: (2019)

Heart Rate Variability as a Marker of Distress and Recovery: The Effect of Brief Supportive Expressive Group Therapy With Mindfulness in Cancer Patients
por: Park, HyeYoun, et al.
Publicado: (2018)

Nano-based delivery of RNAi in cancer therapy
por: Xin, Yong, et al.
Publicado: (2017)

Antitumor therapeutic application of self-assembled RNAi-AuNP nanoconstructs: Combination of VEGF-RNAi and photothermal ablation
por: Son, Sejin, et al.
Publicado: (2017)

Novel RNAi-Based Therapies for Atherosclerosis
por: Ruotsalainen, Anna-Kaisa, et al.
Publicado: (2021)

The Mechanisms Underlying PTEN Loss in Human Tumors Suggest Potential Therapeutic Opportunities
por: Chang, Hyeyoun, et al.
Publicado: (2019)

GenomeRNAi: a database for cell-based RNAi phenotypes
por: Horn, Thomas, et al.
Publicado: (2007)

RNAi for research and therapy
por: Goldman, Michael A
Publicado: (2004)

RNAi-mediated suppression of three carotenoid-cleavage dioxygenase genes, OsCCD1, 4a, and 4b, increases carotenoid content in rice
por: Ko, Mi Ran, et al.
Publicado: (2018)

An RNAi-Based Approach to Down-Regulate a Gene Family In Vivo
por: Kim, Jeehee, et al.
Publicado: (2013)

Immune checkpoint silencing using RNAi-incorporated nanoparticles enhances antitumor immunity and therapeutic efficacy compared with antibody-based approaches
por: Won, Ji Eun, et al.
Publicado: (2022)

Direction-of-Arrival Estimation Based on Frequency Difference–Wavenumber Analysis for Sparse Vertical Array Configuration
por: Kim, Donghyeon, et al.
Publicado: (2022)

Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer
por: Azorsa, David O, et al.
Publicado: (2009)

RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients
por: Golan, Talia, et al.
Publicado: (2015)

Correction: An RNAi-Based Approach to Down-Regulate a Gene Family In Vivo
por: Kim, Jeehee, et al.
Publicado: (2013)

GenomeRNAi: a database for cell-based RNAi phenotypes. 2009 update
por: Gilsdorf, Moritz, et al.
Publicado: (2010)

Antiviral RNAi therapy: emerging approaches for hitting a moving target
por: Leonard, J N, et al.
Publicado: (2005)

Viral Vectors Applied for RNAi-Based Antiviral Therapy
por: Lundstrom, Kenneth
Publicado: (2020)

RNAi-Based Therapy: Combating Shrimp Viral Diseases
por: Alam, Md. Shahanoor, et al.
Publicado: (2023)

RNAi2013: RNAi at Oxford
por: Mulcahy, Laura A, et al.
Publicado: (2013)

Development of patatin knockdown potato tubers using RNA interference (RNAi) technology, for the production of human-therapeutic glycoproteins
por: Kim, Yoon-Sik, et al.
Publicado: (2008)

GenomeRNAi: a database for cell-based and in vivo RNAi phenotypes, 2013 update
por: Schmidt, Esther E., et al.
Publicado: (2013)

The presence of hypertension during pregnancy determines the future risk of metabolic syndrome: An observational study
por: Ju, Da-Hye, et al.
Publicado: (2022)

Harnessing RNAi nanomedicine for precision therapy
por: Peer, Dan
Publicado: (2014)

Prospects for RNAi Therapy of COVID-19
por: Uludağ, Hasan, et al.
Publicado: (2020)

Insight Into the Prospects for RNAi Therapy of Cancer
por: Tian, Zhili, et al.
Publicado: (2021)

Oral delivery of RNAi for cancer therapy
por: Afrin, Humayra, et al.
Publicado: (2023)

Advances with RNAi-Based Therapy for Hepatitis B Virus Infection
por: van den Berg, Fiona, et al.
Publicado: (2020)

Comparison of efficacy between adjuvant chemotherapy and chemoradiation therapy for pancreatic cancer: AJCC stage-based approach
por: You, Min Su, et al.
Publicado: (2020)

E-RNAi: a web application to design optimized RNAi constructs
por: Arziman, Zeynep, et al.
Publicado: (2005)

In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma
por: Sa, Jason K., et al.
Publicado: (2015)

Editorial: RNAi Based Pesticides
por: Székács, András, et al.
Publicado: (2021)

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi
por: Lage, Hermann, et al.
Publicado: (2010)

RNAi2015 – Ten years of RNAi Oxford
por: Bewicke-Copley, Findlay, et al.
Publicado: (2015)

RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy
por: Yoo, Byunghee, et al.
Publicado: (2019)

RNA Interference (RNAi) Induced Gene Silencing: A Promising Approach of Hi-Tech Plant Breeding
por: Younis, Adnan, et al.
Publicado: (2014)

RNAi Therapy for HIV Infection: Principles and Practicalities
por: Bennasser, Yamina, et al.
Publicado: (2012)

RNAi Screening-based Identification of USP10 as a Novel Regulator of Paraptosis
por: Kim, Jin Yeop, et al.
Publicado: (2019)

Development of microRNA-based therapy for pancreatic cancer
por: Fesler, Andrew, et al.
Publicado: (2019)

Selective retina therapy monitoring by speckle variance optical coherence tomography for dosimetry control
por: Lee, Soohyun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1fs5238uprctm2dkk6n13ntjld